Latest News

See All Latest News Right Pointing Arrow
Young man in a pharmacist coat at work
Advocacy Membership

The Role of the IDS Pharmacy Technician

August 12, 2025

Members of the HOPA Investigational Drug Services (IDS) special interest group (SIG) have identified specific responsibilities and duties that differentiate the IDS technician role from other advanced and specialized technician roles.

Latina in military fatigues hugging her school-aged daughter

HOPA to Present BCOP CEs at AVAHO's Annual Meeting

August 04, 2025

AVAHO Pre-Conference features The Pre-Conference features three sessions totaling four hours of Board-Certified Oncology Pharmacist (BCOP) continuing education (CE) credits.

Cancer pill medication
Advocacy Membership

HOPA and Coalition to Improve Access to Cancer Care Commend Reintroduction of Cancer Drug Parity Act

July 14, 2025

HOPA, along with the CIACC, recently voiced its support for the reintroduced Cancer Drug Parity Act, aiming to make oral and self-administered cancer treatments less expensive and more accessible.

School of Pharmacy
Membership HOPA News

No Higher Calling: Reflections on a Career in Higher Education

July 10, 2025

In this essay from the most recent issue of HOPA NEWs, Amber B. Clemmons, PharmD, BCOP, FHOPA, shares reflections and advice from her career in academia.

HOPA logo
Advocacy

HOPA Signs Letters Defending Medicaid, NIH, and More Against Funding Cuts

July 02, 2025

HOPA has joined forces with multiple national health organizations to speak out against proposed cuts to Medicaid, the NIH, and the future of optimized cancer care.

ASCO 2025 attendees
Membership

ASCO 2025 Recap: HOPA's Impact in Chicago

June 05, 2025

On May 30-June 1, a group of eight HOPA staff and volunteers once again traveled to Chicago, Illinois, for the ASCO Annual Meeting - the largest oncology conference in the world, with about 50,000 attendees.

Explore more from HOPA

-positive non-small cell lung cancer
Drug Updates

Pharmacist’s Application to Practice: Repotrectinib

January 25, 2024

Christopher L. Cornett II, PharmD PGY1 Acute Care Pharmacy Resident Anne E Hitron, PharmD, MS, MBA, BCOP ,Oncology Pharmacy Specialist, Baptist Health Louisville, Louisville, Kentucky

Metastatic Colorectal Cancer
Journal Club

Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer

May 04, 2024

The data from this trial confirm that FTD–TPI plus bevacizumab is an effective treatment option for patients with refractory metastatic colorectal cancer, irrespective of mutational status, which side the tumor is on, and whether patients have previously

Late Breaking News

Clinical Oncology Pharmacy Technician: Impact of a New Role on Pharmacy and Patient Metrics at a Large Academic Cancer Center

September 20, 2024

A recently published article details the impact of having an inpatient clinical oncology pharmacy technician program.

Myelofibrosis with anemia
Drug Updates

Pharmacist's Application to Practice: Momelotinib

January 11, 2024

Diana Mansour, PharmD, BCOP, Clinical Pharmacy Specialist, Charles M Gallagher, PharmD, PGY2 Oncology Pharmacy Resident; Kelsea Seago, PharmD, BCOP, Clinical Pharmacy Specialist, allfrom WVUH Hospitals, write about Momelotinib.

Journal Club

Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study

October 23, 2023

Amivantamab–chemotherapy improved PFS and intracranial PFS versus chemotherapy.

Oncology Stewardship
Late Breaking News

Oncology Stewardship Practice in the United States: A Hematology/Oncology Pharmacy Association National Survey

November 26, 2024

A recently published survey looks to gain insight on the current landscape of oncology stewardship in the United States.

uveal melanoma with unresectable hepatic metastases
Drug Updates

Pharmacist’s Application to Practice: Hepzato Kit™

January 11, 2024

Lainey Vargo, PharmD, PGY2-Oncology Resident Katie Murto, PharmD, BCOP and Crystal Heise, PharmD, BCOP WVUH Hospitals, Morgantown, West Virginia.

metastatic non-small cell lung cancer
Journal Club

Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC

November 23, 2023

First-line treatment with osimertinib–chemotherapy led to significantly longer progression-free survival than osimertinib monotherapy among patients with EGFR-mutated advanced NSCLC.

Visual of data being collected
Late Breaking News

Oncology Pharmacy Staffing Survey Across Practice Settings in the United States

September 19, 2024

The results of a recently published pharmacy staffing model survey has brought new insights into oncology pharmacy operations across the country.